US Intercontinental Ballistic Missile Market

ID: MRFR/AD/12201-HCR
100 Pages
Shubham Munde
Last Updated: April 06, 2026
US Intercontinental Ballistic Missile Market Size, Share, Industry Trend & Analysis Research Report: By Type (Tactical Missiles, Strategic Missiles, Submarine-launched Missiles), By Launch Platform (Land-based Launchers, Sea-based Launchers, Airborne Launchers), By Range (Short Range, Medium Range, Long Range, Intercontinental Range) andBy Payload (Conventional Warheads, Nuclear Warheads, Multiple Independently Targetable Reentry Vehicles)- Forecast to 2035
US Intercontinental Ballistic Missile Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.86%
2024 Market Size$ 8.12 Billion
2025 Market Size$ 8.43 Billion
2035 Market Size$ 12.32 Billion
Key Players
Lockheed Martin
Northrop Grumman
Raytheon Technologies
Boeing
General Dynamics
Thales Group
Trends
  • Technological Advancements
  • Geopolitical Dynamics
  • Regulatory Environment
Opportunities
  • Strategic Defense Initiatives
  • International Arms Control Agreements
  • Emerging Threats and Security Concerns
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Type (USD Billion)
      1. 4.1.1 Tactical Missiles
      2. 4.1.2 Strategic Missiles
      3. 4.1.3 Submarine-launched Missiles
    2. 4.2 Pharmaceutical, BY Launch Platform (USD Billion)
      1. 4.2.1 Land-based Launchers
      2. 4.2.2 Sea-based Launchers
      3. 4.2.3 Airborne Launchers
    3. 4.3 Pharmaceutical, BY Range (USD Billion)
      1. 4.3.1 Short Range
      2. 4.3.2 Medium Range
      3. 4.3.3 Long Range
      4. 4.3.4 Intercontinental Range
    4. 4.4 Pharmaceutical, BY Payload (USD Billion)
      1. 4.4.1 Conventional Warheads
      2. 4.4.2 Nuclear Warheads
      3. 4.4.3 Multiple Independently Targetable Reentry Vehicles
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Lockheed Martin (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Northrop Grumman (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Raytheon Technologies (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Boeing (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 General Dynamics (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Thales Group (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 BAE Systems (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Airbus (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY LAUNCH PLATFORM
    4. 6.4 US MARKET ANALYSIS BY RANGE
    5. 6.5 US MARKET ANALYSIS BY PAYLOAD
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 PHARMACEUTICAL, BY LAUNCH PLATFORM, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY LAUNCH PLATFORM, 2024 TO 2035 (USD Billion)
    16. 6.16 PHARMACEUTICAL, BY RANGE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY RANGE, 2024 TO 2035 (USD Billion)
    18. 6.18 PHARMACEUTICAL, BY PAYLOAD, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY PAYLOAD, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY LAUNCH PLATFORM, 2025-2035 (USD Billion)
      3. 7.2.3 BY RANGE, 2025-2035 (USD Billion)
      4. 7.2.4 BY PAYLOAD, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Intercontinental Ballistic Missile Market Segmentation

US Intercontinental Ballistic Missile Market By Type (USD Billion, 2025-2035)

  • Tactical Missiles
  • Strategic Missiles
  • Submarine-launched Missiles

US Intercontinental Ballistic Missile Market By Launch Platform (USD Billion, 2025-2035)

  • Land-based Launchers
  • Sea-based Launchers
  • Airborne Launchers

US Intercontinental Ballistic Missile Market By Range (USD Billion, 2025-2035)

  • Short Range
  • Medium Range
  • Long Range
  • Intercontinental Range

US Intercontinental Ballistic Missile Market By Payload (USD Billion, 2025-2035)

  • Conventional Warheads
  • Nuclear Warheads
  • Multiple Independently Targetable Reentry Vehicles

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.